Skip to main content

Phio Pharmaceuticals Corp

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

PHIO$0.84+4.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

ITEM 6.EXHIBITS

EXHIBIT INDEX

ExhibitIncorporated by Reference Herein
NumberDescriptionFormDate
3.1Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp.Current Report on Form 8-K (File No. 001-36304)November 19, 2018
3.2Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp.Current Report on Form 8-K (File No. 001-36304)January 14, 2020
3.3Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp.Current Report on Form 8-K (File No. 001-36304)January 25, 2023
3.4Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Phio Pharmaceuticals Corp.Current Report on Form 8-K (File No. 001-36304)July 2, 2024
3.5Certificate of Designation of Series D Preferred Stock, dated November 16, 2022.Current Report on Form 8-K (File No. 001-36304)November 16, 2022
3.6Amended and Restated Bylaws of Phio Pharmaceuticals Corp.Current Report on Form 8-K (File No. 001-36304)May 2, 2022
4.1Form of Warrant.Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-221173)September 28, 2018
4.2Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)November 19, 2019
4.3Form of Warrant.Current Report on Form 8-K (File No. 001-36304)February 6, 2020
4.4Form of Warrant.Current Report on Form 8-K (File No. 001-36304)February 13, 2020
4.5Form of Underwriter Warrant.Current Report on Form 8-K (File No. 001-36304)February 13, 2020
4.6Form of Warrant.Current Report on Form 8-K (File No. 001-36304)April 2, 2020
4.7Form of Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)January 25, 2021
4.8Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)February 17, 2021
4.9Form of Series A Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)April 20, 2023
4.10Form of Series B Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)April 20, 2023
4.11Form of Existing Warrant Amendment.Current Report on Form 8-K (File No. 001-36304)April 20, 2023
4.12Form of Series A Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)June 2, 2023
4.13Form of Series B Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)June 2, 2023
4.14Form of Series A/B Warrant.Current Report on Form 8-K (File No. 001-36304)December 8, 2023
4.15Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)December 8, 2023
4.16Form of Series C/D Warrant.Current Report on Form 8-K (File No. 001-36304)July 12, 2024
4.17Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)July 12, 2024
4.18Form of Series E Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)December 20, 2024
4.19Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)December 20, 2024
4.20Form of Series F Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)December 26, 2024
4.21Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)December 26, 2024
4.22Form of Series G Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)January 14, 2025
4.23Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)January 14, 2025
4.24Form of Series H Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)January 15, 2025
4.25Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)January 15, 2025
4.26Form of Series I Common Stock Warrant.Current Report on Form 8-K (File No. 001-36304)January 17, 2025
4.27Form of Placement Agent Warrant.Current Report on Form 8-K (File No. 001-36304)January 17, 2025
10.1Form of Securities Purchase Agreement, dated January 13, 2025,Current Report on Form 8-K (File No. 001-36304)January 14, 2025
by and between the Company and each of the Purchasers signatory thereto.
10.2Form of Securities Purchase Agreement, dated January 14, 2025,Current Report on Form 8-K (File No. 001-36304)January 15, 2025
by and between the Company and each of the Purchasers signatory thereto.
10.3Form of Securities Purchase Agreement, dated January 16, 2025,Current Report on Form 8-K (File No. 001-36304)January 17, 2025
by and between the Company and each of the Purchasers signatory thereto.
10.4#First Amendment to the Employment Agreement of Robert J. Bitterman, dated March 25, 2025, by and between the Company and Robert Bitterman.Annual Report on Form 10-K (File No. 001-36304)March 31, 2025
31.1Sarbanes-Oxley Act Section 302 Certification of Principal Executive Officer.*
31.2Sarbanes-Oxley Act Section 302 Certification of Principal Financial Officer.*
32.1Sarbanes-Oxley Act Section 906 Certification of Principal Executive Officer and Principal Financial Officer.**
101.INSInline XBRL Instance Document.*
101.SCHInline XBRL Taxonomy Extension Schema Document.*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.*
104The cover page for this report, formatted in Inline XBRL (included in Exhibit 101).*
_________________
*Filed herewith.
**Furnished herewith and not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section or incorporated by reference into any filing under the Securities Act or the Exchange Act.
#Indicates a management contract or compensatory plan or arrangement.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.